About RUWAG
RUWAG is a company based in Bettlach (Switzerland) founded in 1987 was acquired by Calibre Scientific in January 2024. RUWAG offers products and services including Diagnostics Products, Life Science Products, and Allergy Products. RUWAG operates in a competitive market with competitors including AmerisourceBergen, Xantis Pharma, DCS Pharma, Globomedica and The Genetics, among others.
- Headquarter Bettlach, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ruwag Handels Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Calibre Scientific
(Jan 22, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RUWAG
RUWAG offers a comprehensive portfolio of products and services, including Diagnostics Products, Life Science Products, and Allergy Products.
Products for testing and diagnostics in healthcare settings
Tools for research and development in life sciences
Items for allergy testing and related applications
Funding Insights of RUWAG
Detailed funding history for RUWAG
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in RUWAG
RUWAG has secured backing from 1 investor. Prominent investors backing the company include Calibre Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of contract based research, manufacturing, distribution and other services for biopharma sector
|
Locked | Locked | Locked |
Investor details for RUWAG
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RUWAG
Investment portfolio details for RUWAG
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RUWAG
Detailed financials for RUWAG
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ruwag Comparisons
Peer comparison for RUWAG
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RUWAG
RUWAG operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Xantis Pharma, DCS Pharma, Globomedica and The Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Distributor of generic prescription and over-the-counter products
|
|
| Locked | Locked | Locked |
Pharmaceutical products are distributed by DCS Pharma in Switzerland.
|
|
| Locked | Locked | Locked |
Diversified pharmaceutical drugs are distributed by Globomedica in Switzerland.
|
|
| Locked | Locked | Locked |
Develops and commercializes small molecule inhibitors for cancer and Alzheimer's disease therapies.
|
Detailed competitors of RUWAG
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ruwag
Complete news archive for RUWAG
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RUWAG
RUWAG was founded in 1987.
RUWAG is headquartered in Bettlach, Switzerland. It is registered at Bettlach, Solothurn, Switzerland.
RUWAG was established in 1987 in Bettlach, Switzerland, as a distributor in the life sciences sector. Diagnostic instruments, transfection devices, and biobanking solutions are provided to support research and medical applications. Additionally, accessories for power tools are supplied to the artisan and DIY markets. Operations focus on efficient distribution across these specialized areas within Switzerland.
RUWAG's top competitors include AmerisourceBergen, DCS Pharma and Globomedica.
RUWAG offers Diagnostics Products, Life Science Products, and Allergy Products.
RUWAG has 1 investor. Key investors include Calibre Scientific.